Pemetrexed monotherapy for chemo-na < ve elderly (aged ae<yen>80) patients with non-squamous non-small cell lung cancer: results from combined analysis of two single arm phase II studies (HANSHIN002 and 003)

Hata Akito; Katakami Nobuyuki; Hattori Yoshihiro; Tanaka Kosuke; Fujita Shiro; Kotani Yoshikazu; Nishimura Takashi; Imamura Fumio; Yokota Soichiro; Satouchi Miyako; Monden Kazuya; Otsuka Kojiro; Nishiyama Akihiro; Tsubouchi Kazuya; Kaneda Toshihiko; Yoshioka Hiroshige; Morita Satoshi; Negoro Shunichi

首页> 外文期刊>Cancer chemotherapy and pharmacology. >Pemetrexed monotherapy for chemo-na < ve elderly (aged ae80) patients with non-squamous non-small cell lung cancer: results from combined analysis of two single arm phase II studies (HANSHIN002 and 003)

【24h】

Pemetrexed monotherapy for chemo-na < ve elderly (aged ae80) patients with non-squamous non-small cell lung cancer: results from combined analysis of two single arm phase II studies (HANSHIN002 and 003)

机译：用于化疗的聚合物 - NA 80）非鳞状非小细胞肺癌患者的疗法单药治疗：两种单臂期II研究的组合分析结果（Hanshin002和003）

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

The aim of this retrospective study was to evaluate via combined analysis the efficacy and safety of pemetrexed monotherapy for chemo-na < ve elderly patients aged ae80 with non-squamous non-small cell lung cancer (NSCLC).

机译：该回顾性研究的目的是通过组合分析化学-NA 80与非鳞状非小细胞肺癌（NSCLC）进行化学-NA

著录项

来源
《Cancer chemotherapy and pharmacology.》 |2017年第4期|共7页
作者
Hata Akito; Katakami Nobuyuki; Hattori Yoshihiro; Tanaka Kosuke; Fujita Shiro; Kotani Yoshikazu; Nishimura Takashi; Imamura Fumio; Yokota Soichiro; Satouchi Miyako; Monden Kazuya; Otsuka Kojiro; Nishiyama Akihiro; Tsubouchi Kazuya; Kaneda Toshihiko; Yoshioka Hiroshige; Morita Satoshi; Negoro Shunichi;
展开▼
作者单位

Inst Biomed Res &

Innovat Div Integrated Oncol Chuo Ku 2-2 Minatojima Minamimachi Kobe Hyogo;

Inst Biomed Res &

Innovat Div Integrated Oncol Chuo Ku 2-2 Minatojima Minamimachi Kobe Hyogo;

Hyogo Canc Ctr Dept Thorac Oncol Akashi Hyogo Japan;

Inst Biomed Res &

Innovat Div Integrated Oncol Chuo Ku 2-2 Minatojima Minamimachi Kobe Hyogo;

Inst Biomed Res &

Innovat Div Integrated Oncol Chuo Ku 2-2 Minatojima Minamimachi Kobe Hyogo;

Kobe Univ Hosp Dept Resp Med Kobe Hyogo Japan;

Kyoto Katsura Hosp Dept Resp Med Kyoto Japan;

Osaka Med Ctr Canc &

Cardiovasc Dis Dept Resp Med Osaka Japan;

Toneyama Natl Hosp Dept Thorac Oncol Natl Hosp Org Toyonaka Osaka Japan;

Hyogo Canc Ctr Dept Thorac Oncol Akashi Hyogo Japan;

Kobe City Med Ctr Gen Hosp Dept Resp Med Kobe Hyogo Japan;

Kobe City Med Ctr Gen Hosp Dept Resp Med Kobe Hyogo Japan;

Kurashiki Cent Hosp Dept Resp Med Kurashiki Okayama Japan;

Kurashiki Cent Hosp Dept Resp Med Kurashiki Okayama Japan;

Kurashiki Cent Hosp Dept Resp Med Kurashiki Okayama Japan;

Kurashiki Cent Hosp Dept Resp Med Kurashiki Okayama Japan;

Kyoto Univ Dept Biomed Stat &

Bioinformat Grad Sch Med Kyoto Japan;

Hyogo Canc Ctr Dept Thorac Oncol Akashi Hyogo Japan;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药理学;
关键词
Pemetrexed; Elderly; Non-squamous non-small cell lung cancer;

机译：Pemetrexed;老年人;非鳞状非小细胞肺癌;

相似文献

外文文献
中文文献
专利

1. Pemetrexed monotherapy for chemo-na < ve elderly (aged ae80) patients with non-squamous non-small cell lung cancer: results from combined analysis of two single arm phase II studies (HANSHIN002 and 003) [J] . Hata Akito, Katakami Nobuyuki, Hattori Yoshihiro, Cancer chemotherapy and pharmacology. . 2017,第4期

机译：用于化疗的聚合物 - NA 80）非鳞状非小细胞肺癌患者的疗法单药治疗：两种单臂期II研究的组合分析结果（Hanshin002和003）
2. A phase II study of pemetrexed monotherapy in chemo-na < ve Eastern Cooperative Oncology Group performance status 2 patients with EGFR wild-type or unknown advanced non-squamous non-small cell lung cancer (HANSHIN Oncology Group 002) [J] . Hata Akito, Katakami Nobuyuki, Fujita Shiro, Cancer chemotherapy and pharmacology. . 2015,第6期

机译：培美曲塞单药治疗东部化疗合作组II状态临床研究2例EGFR野生型或未知晚期非鳞状非小细胞肺癌患者（HANSHIN Oncology Group 002）
3. A phase II study of pemetrexed in chemotherapy-na?ve elderly patients aged ≥75 years with advanced non-squamous non-small-cell lung cancer (HANSHIN Oncology Group 003) [J] . HattoriY., IwasakuM., SatouchiM., Japanese journal of clinical oncology. . 2013,第12期

机译：培美曲塞Ⅱ期研究在≥75岁的初次接受化疗的老年患者中患有晚期非鳞状非小细胞肺癌（HANSHIN Oncology Group 003）
4. Pemetrexed versus docetaxel single agent chemotherapy in chemotherapy-naive elderly patients with advanced non-small cell lung cancer [C] . Hua Xin, Zhenguo Han, Haibo Huang 2011 International Conference on Human Health and Biomedical Engineering . 2011

机译：培美曲塞与多西他赛单药化疗在未接受化疗的老年晚期非小细胞肺癌患者中的作用
5. A Study of Erlotinib Monotherapy and in Combination with Pembrolizumab in Previously Untreated Stage I-IIIA Non-small Cell Lung Cancer [D] . Liu, Qiong. 2021

机译：Erlotinib单疗法和蛋白质在先前未处理阶段I-IIIA非小细胞肺癌中的研究
6. Prospective multicentre single-arm phase II trial of pembrolizumab combined with carboplatin and pemetrexed in elderly patients with advanced non-squamous non-small cell lung cancer [O] . Yuichi Ozawa, Takeya Sugimoto, Yuichiro Azuma, 2020

机译：前瞻性多方形彭布罗齐押的单臂期二试验与老年人晚期非鳞状非小细胞肺癌的老年人患者联合卡铂和培养基
7. A Phase II Study of Pemetrexed in Chemotherapy-naive Elderly Patients Aged >=75 years with Advanced Non-squamous Non-small-cell Lung Cancer (HANSHIN Oncology Group 003) [O] . Y. Hattori, M. Iwasaku, M. Satouchi, 2013

机译：培美曲塞在晚期非鳞状非小细胞肺癌年龄≥75岁的化疗患者中的第二阶段研究（HaNsHIN Oncology Group 003）

Pemetrexed monotherapy for chemo-na < ve elderly (aged ae80) patients with non-squamous non-small cell lung cancer: results from combined analysis of two single arm phase II studies (HANSHIN002 and 003)

摘要

著录项

相似文献

相关主题

期刊订阅